Trial · NCT02573467
Results by group84
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 84
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Participants With Adverse Events (AEs), Serious Adverse Events (SAEs) and Deaths. | BYM338/Bimagrumab 10 mg/kg | Adverse events | 48 | Participants | |
| Number of Participants With Adverse Events (AEs), Serious Adverse Events (SAEs) and Deaths. | BYM338/Bimagrumab 3 mg/kg | Adverse events | 50 | Participants | |
| Number of Participants With Adverse Events (AEs), Serious Adverse Events (SAEs) and Deaths. | BYM338/Bimagrumab 1 mg/kg | Adverse events | 44 | Participants | |
| Number of Participants With Adverse Events (AEs), Serious Adverse Events (SAEs) and Deaths. | Placebo | Adverse events | 49 | Participants | |
| Number of Participants With Adverse Events (AEs), Serious Adverse Events (SAEs) and Deaths. | BYM338/Bimagrumab 10 mg/kg | Serious adverse events | 12 | Participants | |
| Number of Participants With Adverse Events (AEs), Serious Adverse Events (SAEs) and Deaths. | BYM338/Bimagrumab 3 mg/kg | Serious adverse events | 10 | Participants | |
| Number of Participants With Adverse Events (AEs), Serious Adverse Events (SAEs) and Deaths. | BYM338/Bimagrumab 1 mg/kg | Serious adverse events | 7 | Participants | |
| Number of Participants With Adverse Events (AEs), Serious Adverse Events (SAEs) and Deaths. | Placebo | Serious adverse events | 8 | Participants | |
| Number of Participants With Adverse Events (AEs), Serious Adverse Events (SAEs) and Deaths. | BYM338/Bimagrumab 10 mg/kg | Deaths | 1 | Participants | |
| Number of Participants With Adverse Events (AEs), Serious Adverse Events (SAEs) and Deaths. | BYM338/Bimagrumab 3 mg/kg | Deaths | 1 | Participants | |
| Number of Participants With Adverse Events (AEs), Serious Adverse Events (SAEs) and Deaths. | BYM338/Bimagrumab 1 mg/kg | Deaths | 1 | Participants | |
| Number of Participants With Adverse Events (AEs), Serious Adverse Events (SAEs) and Deaths. | Placebo | Deaths | 2 | Participants | |
| Change From Core Study Baseline in 6 Minute Walking Distance Test (6MWD) | BYM338/Bimagrumab 10 mg/kg | Week 52 (n=53,52,51,54) | 6.88 | Standard Deviation 68.948 | meters |
| Change From Core Study Baseline in 6 Minute Walking Distance Test (6MWD) | BYM338/Bimagrumab 3 mg/kg | Week 52 (n=53,52,51,54) | 9.48 | Standard Deviation 81.676 | meters |
| Change From Core Study Baseline in 6 Minute Walking Distance Test (6MWD) | BYM338/Bimagrumab 1 mg/kg | Week 52 (n=53,52,51,54) | -14.26 | Standard Deviation 81.029 | meters |
| Change From Core Study Baseline in 6 Minute Walking Distance Test (6MWD) | Placebo | Week 52 (n=53,52,51,54) | -5.98 | Standard Deviation 78.817 | meters |
| Change From Core Study Baseline in 6 Minute Walking Distance Test (6MWD) | BYM338/Bimagrumab 10 mg/kg | Week 78 | -5.25 | Standard Deviation 122.002 | meters |
| Change From Core Study Baseline in 6 Minute Walking Distance Test (6MWD) | BYM338/Bimagrumab 3 mg/kg | Week 78 | -9.73 | Standard Deviation 68.302 | meters |
| Change From Core Study Baseline in 6 Minute Walking Distance Test (6MWD) | BYM338/Bimagrumab 1 mg/kg | Week 78 | -18.66 | Standard Deviation 81.536 | meters |
| Change From Core Study Baseline in 6 Minute Walking Distance Test (6MWD) | Placebo | Week 78 | -32.78 | Standard Deviation 96.494 | meters |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02573467/results